Tranexamic Acid
Lysine-derivative antifibrinolytic in USP grade for tablet and injectable formulation manufacturing. Sourced for haemostatic and heavy-menstrual-bleeding product lines.
Pharmaceutical & Life Science Solutions
Broad-spectrum APIs spanning CNS, cardiovascular, urology, and metabolic indications — plus enzyme and biologic preparations. Supplied in pharmaceutical grade for diverse formulation manufacturing across primary and specialty care product lines.
Lysine-derivative antifibrinolytic in USP grade for tablet and injectable formulation manufacturing. Sourced for haemostatic and heavy-menstrual-bleeding product lines.
Partial fatty-acid oxidation inhibitor supplied as dihydrochloride salt — the standard trading form — for oral tablet formulation manufacturing. Sourced for antianginal/metabolic-modifier product lines.
Alpha-2 adrenergic antagonist alkaloid supplied as hydrochloride salt for oral tablet formulation manufacturing. Sourced for peripheral vasoactive and erectile-dysfunction adjunct product lines.
GABA-A agonist hypnotic supplied as tartrate salt — the standard trading form, USP grade — for oral tablet formulation manufacturing. Note: controlled substance in most jurisdictions.